Abstract

Understanding the cellular and molecular basis of selective vulnerability has been challenging, especially for motor neuron diseases. Developing drugs that improve the health of neurons that display selective vulnerability relies on in vivo cell-based models and quantitative readout measures that translate to patient outcome. We initially developed and characterized UCHL1-eGFP mice, in which motor neurons are labeled with eGFP that is stable and long-lasting. By crossing UCHL1-eGFP to amyotrophic lateral sclerosis (ALS) disease models, we generated ALS mouse models with fluorescently labeled motor neurons. Their examination over time began to reveal the cellular basis of selective vulnerability even within the related motor neuron pools. Accumulation of misfolded SOD1 protein both in the corticospinal and spinal motor neurons over time correlated with the timing and extent of degeneration. This further proved simultaneous degeneration of both upper and lower motor neurons, and the requirement to consider both upper and lower motor neuron populations in drug discovery efforts. Demonstration of the direct correlation between misfolded SOD1 accumulation and motor neuron degeneration in both cortex and spinal cord is important for building cell-based assays in vivo. Our report sets the stage for shifting focus from mice to diseased neurons for drug discovery efforts, especially for motor neuron diseases.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is a motor disease characterized by the loss of upper and lower motor neurons

  • We investigate the presence of a direct correlation between misfolded SOD1 accumulation and motor neuron vulnerability in both cortex and spinal cord throughout the disease

  • Mice (Figure 1a) after corticospinal motor neurons (CSMN) identity of eGFP+ neurons in layer 5 of the motor cortex were confirmed and the numbers of GFP+ CSMN were significantly reduced with disease progression starting at

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is a motor disease characterized by the loss of upper and lower motor neurons. Not all motor neurons are vulnerable to degeneration to the same extent in ALS. Not all corticospinal motor neurons (CSMN) degenerate to the same extent even at the end-stage. The reason for this varying degree of vulnerability and resistance to degeneration is not fully understood. Misfolded proteins are a hallmark of neurodegenerative diseases [8,9] including ALS [10,11]. Toxic gain of function of mutated misfolded SOD1 protein has been one of the most-widely studied underlying causes of ALS [7], but even today we do not know why different motor neuron pools display a wide range of

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call